Cost-Effectiveness of Extended-Release Carbidopa-Levodopa for Advanced Parkinson's Disease.
- Published in:
- American Journal of Pharmacy Benefits, 2017, v. 9, n. 1, p. 23
- By:
- Publication type:
- Article
Works matching IS 19454481 AND DT 2017 AND VI 9 AND IP 1
Results: 5
1
2
Patient Characteristics' Effect on the Conversion Between Basal Insulins.
- Published in:
- American Journal of Pharmacy Benefits, 2017, v. 9, n. 1, p. 17
- By:
- Publication type:
- Article
3
Modeled Cost Differences Associated With Use of Levonorgestrel Intrauterine Devices.
- Published in:
- American Journal of Pharmacy Benefits, 2017, v. 9, n. 1, p. 12
- By:
- Publication type:
- Article
4
What Are Key Considerations for Health Reform?
- Published in:
- American Journal of Pharmacy Benefits, 2017, v. 9, n. 1, p. 30
- By:
- Publication type:
- Article
5
The Value of Vaccination: Myth vs Evidence in the New Administration.
- Published in:
- American Journal of Pharmacy Benefits, 2017, v. 9, n. 1, p. 11
- By:
- Publication type:
- Article